Congenital CMV: The Importance of Prevention, Early Screening and Treatment

Congenital cytomegalovirus (cCMV) is the most common infectious cause of congenital disabilities in the United States, affecting about 1 in 200 infants born each year

January 24, 2025
7 min

Phoenix Children's Medical Connection

Overview

Congenital cytomegalovirus (cCMV) is the leading infectious cause of congenital disabilities in the U.S., affecting approximately 1 in 200 infants. Early detection and intervention are crucial for improving outcomes, yet cCMV remains underdiagnosed and under-recognized.

Background

cCMV can lead to significant long-term health issues, including hearing loss and developmental delays, making awareness and early intervention vital. Despite its prevalence, many healthcare providers lack knowledge about cCMV, resulting in missed opportunities for prevention and treatment. Addressing this knowledge gap is essential for improving care for affected infants and their families.

Data Highlights

No numerical data provided in the article.

Key Findings

cCMV affects about 1 in 200 infants born each year in the U.S.
Approximately 10% of infants with cCMV show symptoms at birth, with half facing long-term health challenges.
Simple behavioral changes can significantly reduce the risk of CMV transmission during pregnancy.
Early screening for cCMV is not routine, leading to delayed diagnosis and intervention.
Raising awareness among healthcare providers and patients is critical for improving outcomes.

Clinical Implications

Healthcare providers should prioritize educating patients about cCMV prevention strategies during prenatal visits. Implementing early screening protocols can facilitate timely interventions, ultimately improving the quality of life for affected children.

Conclusion

Enhancing awareness and early detection of cCMV is essential for reducing its impact on infants and families. Ongoing education and advocacy efforts are necessary to bridge the knowledge gap in healthcare settings.